Winder AD, Johnson S, Murphy), et al: Epidural analgesia for treatment of a sickle cell crisis during pregnancy. Obstet Gynecol 118(2 Pt 2):495,t2011 Wright DE, Rosovsky RP, Platt MY: Case 36-2013: a 38-year-old woman with anemia and thrombocytopenia. N Englt) Med 369:21, 2013
World Health Organization: Guideline: daily iron and folic acid supplementation in pregnant women. 2012. Available at: http://apps.who.int/iris/bitstr eam/1t0665/77770/1/9789241501996_eng.pd?ua = 1. Accessed November 9, 2016
Wyszynski DF, Carman W], Cantor AB, et al: Pregnancy and birth outcomes among women with idiopathic thrombocytopenic purpura. ) Pregnancy 2016:829740 ,2016
Xiong L, Barrett AN, Hua R, et al: Non-invasive prenatal diagnostic testing for 3-thalassaemia using cell-free fetal DNA and next generation sequencing. Prenat Diagn 35(3):258, 2015
Yawata Y, Kanzaki A, Yawata A, et al: Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int) Hematol 71:118, 2000
Yeomans E, Lowe W, Eigenbrodt EH, et al: Liver histopathologic indings in women with sickle cell disease given prophylactic transfusion during pregnancy. m)Obstet Gynecol 163:958, 1990
Young NS: Bone marrow failure syndromes including aplastic anemia and myelodysplasia. In: Kasper DL, Fauci AS, Hauser SL, et al (eds): Harrison's Principles of Internal Medicine, 19th ed. New York, McGraw-Hill Education, 2015
Yu CK, Stasiowska E, Stephens A, et al: Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. ) Obstet Gynaecol 29(6):512, 2009
Zhen L, Pen M, Han), et al: Non-invasive prenatal detection of haemoglobin Bart's disease by cardiothoracic ratio during the irst trimester. Eurt) Obstet Gynecol Reprod Bioi 193:92, 2015
Ziaei S, Norrozi M, Faghihzadeh S, et al: A randomized placebo-controlled trial to determine the efect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin : 13.2 g/dl. B)OG 114:684, 2007
TYPES OF DIABETES. . . . . . . . . . . . . . . . . . . . . . . . . . .. 1097
PREGESTATIONAL DIABETES .....i...i...i....i.....i....1098
DIAGNOSIS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1098
FETAL EFFECTS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 1099
MATERNAL EFFECTS.. . . . . . . . . . . . . . . . . . . . . . . . . .. 1103
MANAGEMENT OF DIABETES IN PREGNANCY . . . . .. 1104